Skip to main navigation
InVivo Therapeutics

Invivo - Investor Relations

  • About Us
  • Our Technology
  • Our Pipeline
  • Patients & Families
  • Unmet Need
  • Physicians
  • Investors & Media
    • Overview
    • Press Releases
    • Events
    • Presentations
    • Stock Information
      • Stock Quote
      • Stock Chart
    • SEC Filings
    • Corporate Governance
      • Governance Documents
      • Committee Composition
      • Board Diversity Matrix
    • Investor FAQs
    • Email Alerts

Invivo - Investor Relations

  • About Us
  • Our Technology
  • Our Pipeline
  • Patients & Families
  • Unmet Need
  • Physicians
  • Investors & Media
    • Overview
    • Press Releases
    • Events
    • Presentations
    • Stock Information
      • Stock Quote
      • Stock Chart
    • SEC Filings
    • Corporate Governance
      • Governance Documents
      • Committee Composition
      • Board Diversity Matrix
    • Investor FAQs
    • Email Alerts

SEC Filing Details

SEC Filing Details

Document Details

Form
DEFA14A
Filing Date
Sep 6, 2022
Document Date
Sep 6, 2022
Form Description
Additional proxy soliciting materials - definitive
Filing Group
Proxy Filings
Company
Invivo Therapeutics
Issuer
INVIVO THERAPEUTICS HOLDINGS CORP.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

Invivo - Investor Tools

  • Print Page
  • Email Alerts
  • RSS Feeds
  • Contact IR

© 2023 Invivo Therapeutics

Invivo - Site Footer Menu

  • Privacy Policy
  • Terms of Service
  • Subscribe
  • Twitter
  • Facebook
  • LinkedIn